Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Oct 29, 2018 United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo® Oct 15, 2018 Theratechnologies Appoints New Board Member Oct 04, 2018 Theratechnologies Announces Financial Results for the Third Quarter of 2018 Oct 03, 2018 PHARMACOKINETIC PROFILE OF TROGARZOTM PRESENTED AT IDWEEK Sep 28, 2018 LYNE FORTIN TO LEAVE THERATECHNOLOGIES BY YEAR-END Sep 28, 2018 THERATECHNOLOGIES’ CFO TO ATTEND CANTOR GLOBAL HEALTHCARE CONFERENCE IN NEW YORK CITY Sep 27, 2018 THERATECHNOLOGIES TO ANNOUNCE FINANCIAL RESULTS FOR THIRD QUARTER 2018 Sep 14, 2018 EUROPEAN MEDICINES AGENCY VALIDATES MARKETING AUTHORIZATION APPLICATION FOR TROGARZO™ Sep 05, 2018 FDA CONFIRMS TARGET DECISION DATE FOR NOVEL SINGLE-VIAL FORMULATION OF EGRIFTA® (TESAMORELIN FOR INJECTION) Aug 28, 2018 THERATECHNOLOGIES FILES MARKETING AUTHORIZATION APPLICATION FOR TROGARZO™ IN EUROPE First page « Previous page ‹ … Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Page 26 Page 27 … Next page › Last page » Displaying 221 - 230 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Oct 29, 2018 United States Department of Health and Human Services Publishes New HIV Treatment Guidelines Including Trogarzo®
Sep 05, 2018 FDA CONFIRMS TARGET DECISION DATE FOR NOVEL SINGLE-VIAL FORMULATION OF EGRIFTA® (TESAMORELIN FOR INJECTION)